Biogenic Selenium Nanoparticles Attenuate Aβ25–35-Induced Toxicity in PC12 Cells via Akt/CREB/BDNF Signaling Pathway
暂无分享,去创建一个
Xiaofan Song | Chunlan Xu | Lei Qiao | Yue Chen | Xina Dou
[1] Xiaofan Song,et al. Dietary supplementation with biogenic selenium nanoparticles alleviate oxidative stress-induced intestinal barrier dysfunction , 2022, npj Science of Food.
[2] K. Tam,et al. Pathological mechanisms and therapeutic strategies for Alzheimer’s disease , 2021, Neural regeneration research.
[3] E. Bodur,et al. cAMP/PKA-CREB-BDNF signaling pathway in hippocampus of rats subjected to chemically-induced phenylketonuria , 2021, Metabolic brain disease.
[4] D. Öngür,et al. Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer’s disease: A meta-analysis of in vivo magnetic resonance spectroscopy studies , 2021, Ageing Research Reviews.
[5] G. Zheng,et al. Oral Administration of Resveratrol-Selenium-Peptide Nanocomposites Alleviates Alzheimer's Disease-like Pathogenesis by Inhibiting Aβ Aggregation and Regulating Gut Microbiota. , 2021, ACS applied materials & interfaces.
[6] V. Baliga,et al. Cardiometabolic Modification of Amyloid Beta in Alzheimer’s Disease Pathology , 2021, Frontiers in Aging Neuroscience.
[7] Hong Yang,et al. Recent development in Se-enriched yeast, lactic acid bacteria and bifidobacteria , 2021, Critical reviews in food science and nutrition.
[8] R. Karaman,et al. Comprehensive Review on Alzheimer’s Disease: Causes and Treatment , 2020, Molecules.
[9] M. Kim,et al. Lupeol, a Plant-Derived Triterpenoid, Protects Mice Brains against Aβ-Induced Oxidative Stress and Neurodegeneration , 2020, Biomedicines.
[10] Yong-Ku Kim,et al. CREB and BDNF: Neurobiology and treatment of Alzheimer's disease. , 2020, Life sciences.
[11] L. Shaw,et al. Selenium detoxification is required for cancer cell survival , 2020, Nature metabolism.
[12] Xiaochuan Wang,et al. ω-3PUFAs Improve Cognitive Impairments Through Ser133 Phosphorylation of CREB Upregulating BDNF/TrkB Signal in Schizophrenia , 2020, Neurotherapeutics.
[13] Jian-Zhi Wang,et al. ω-3PUFAs Improve Cognitive Impairments Through Ser133 Phosphorylation of CREB Upregulating BDNF/TrkB Signal in Schizophrenia , 2020, Neurotherapeutics.
[14] Chunlan Xu,et al. Biogenic selenium nanoparticles synthesized by Lactobacillus casei ATCC 393 alleviate diquat-induced intestinal barrier dysfunction in C57BL/6 mice through their antioxidant activity. , 2020, Food & function.
[15] S. Sadigh-Eteghad,et al. β-Lapachone attenuates cognitive impairment and neuroinflammation in beta-amyloid induced mouse model of Alzheimer's disease. , 2020, International immunopharmacology.
[16] P. Mandal,et al. Quantitation of in vivo brain glutathione conformers in cingulate cortex among age‐matched control, MCI, and AD patients using MEGA‐PRESS , 2019, Human brain mapping.
[17] S. Lunte,et al. Carnosine Prevents Aβ-Induced Oxidative Stress and Inflammation in Microglial Cells: A Key Role of TGF-β1 , 2019, Cells.
[18] Liegang Liu,et al. Procyanidins Extracted from Lotus Seedpod Ameliorate Amyloid-β-Induced Toxicity in Rat Pheochromocytoma Cells , 2018, Oxidative medicine and cellular longevity.
[19] Blaine R. Roberts,et al. Supranutritional Sodium Selenate Supplementation Delivers Selenium to the Central Nervous System: Results from a Randomized Controlled Pilot Trial in Alzheimer’s Disease , 2018, Neurotherapeutics.
[20] YiLong Dong,et al. Involvement of Akt/CREB signaling pathways in the protective effect of EPA against interleukin-1β-induced cytotoxicity and BDNF down-regulation in cultured rat hippocampal neurons , 2018, BMC Neuroscience.
[21] Peter R Hoffmann,et al. Selenium, Selenoproteins, and Immunity , 2018, Nutrients.
[22] Chunlan Xu,et al. Preparation, characteristics and antioxidant activity of polysaccharides and proteins-capped selenium nanoparticles synthesized by Lactobacillus casei ATCC 393. , 2018, Carbohydrate polymers.
[23] Xiaoliang Wang,et al. L-3-n-Butylphthalide Regulates Proliferation, Migration, and Differentiation of Neural Stem Cell In Vitro and Promotes Neurogenesis in APP/PS1 Mouse Model by Regulating BDNF/TrkB/CREB/Akt Pathway , 2018, Neurotoxicity Research.
[24] M. Nazıroğlu,et al. Nanoparticles as potential clinical therapeutic agents in Alzheimer’s disease: focus on selenium nanoparticles , 2017, Expert review of clinical pharmacology.
[25] Blaine R. Roberts,et al. Glutathione peroxidase 4: a new player in neurodegeneration? , 2017, Molecular Psychiatry.
[26] C. Cotman,et al. IL-1β impairs retrograde flow of BDNF signaling by attenuating endosome trafficking , 2017, Journal of Neuroinflammation.
[27] Xi Zhang,et al. Selenium status and cardiovascular diseases: meta-analysis of prospective observational studies and randomized controlled trials , 2016, European Journal of Clinical Nutrition.
[28] S. Serini,et al. Reduction of Oxidative/Nitrosative Stress in Brain and its Involvement in the Neuroprotective Effect of n-3 PUFA in Alzheimer's Disease. , 2016, Current Alzheimer research.
[29] Mustafa Karapirli,et al. A comparison of hair and serum trace elements in patients with Alzheimer disease and healthy participants. , 2015, Turkish journal of medical sciences.
[30] Elyse Rosa,et al. CREB expression mediates amyloid β-induced basal BDNF downregulation , 2015, Neurobiology of Aging.
[31] A. Chauhan,et al. Glutathione redox imbalance in brain disorders , 2015, Current opinion in clinical nutrition and metabolic care.
[32] T. Kiyota,et al. Effects of multifunctional antioxidants on mitochondrial dysfunction and amyloid-β metal dyshomeostasis. , 2015, Journal of Alzheimer's disease : JAD.
[33] L. Tan,et al. Brain-Derived Neurotrophic Factor in Alzheimer’s Disease: Risk, Mechanisms, and Therapy , 2015, Molecular Neurobiology.
[34] A. Sadhu,et al. Management of Cognitive Determinants in Senile Dementia of Alzheimer’s Type: Therapeutic Potential of a Novel Polyherbal Drug Product , 2014, Clinical Drug Investigation.
[35] Ji-xia Zhang,et al. Antidepressant activity of astilbin: involvement of monoaminergic neurotransmitters and BDNF signal pathway. , 2014, Biological & pharmaceutical bulletin.
[36] H. Steinbrenner,et al. Selenium and Selenoproteins in Inflammatory Bowel Diseases and Experimental Colitis , 2014, Inflammatory bowel diseases.
[37] Pradeep J. Nathan,et al. BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases , 2013, Nature Reviews Neuroscience.
[38] A. Richardson,et al. Gpx4 ablation in adult mice results in a lethal phenotype accompanied by neuronal loss in brain. , 2012, Free radical biology & medicine.
[39] W. Jacob-Filho,et al. Nutritional status of selenium in Alzheimer's disease patients , 2009, British Journal of Nutrition.
[40] W. Markesbery,et al. Organoselenium (Sel-Plex diet) decreases amyloid burden and RNA and DNA oxidative damage in APP/PS1 mice. , 2009, Free radical biology & medicine.
[41] M. Mattson. Pathways towards and away from Alzheimer's disease , 2004, Nature.
[42] S. Weintraub,et al. Anti-apoptotic proteins are oxidized by Abeta25-35 in Alzheimer's fibroblasts. , 2003, Biochimica et biophysica acta.
[43] T. Nabeshima,et al. Amyloid β‐peptide induces nitric oxide production in rat hippocampus: association with cholinergic dysfunction and amelioration by inducible nitric oxide synthase inhibitors , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.